TODDE, SERGIO CAMILLO
 Distribuzione geografica
Continente #
NA - Nord America 7.027
AS - Asia 4.215
EU - Europa 3.631
SA - Sud America 499
AF - Africa 71
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 6
Totale 15.456
Nazione #
US - Stati Uniti d'America 6.852
VN - Vietnam 1.390
SG - Singapore 1.013
CN - Cina 927
IT - Italia 714
DE - Germania 659
RU - Federazione Russa 493
SE - Svezia 481
HK - Hong Kong 464
BR - Brasile 409
IE - Irlanda 302
UA - Ucraina 236
GB - Regno Unito 225
FI - Finlandia 144
CA - Canada 133
AT - Austria 84
FR - Francia 82
KR - Corea 78
IN - India 72
ID - Indonesia 57
AR - Argentina 43
NL - Olanda 39
DK - Danimarca 36
ZA - Sudafrica 35
JP - Giappone 33
TR - Turchia 32
BD - Bangladesh 28
PL - Polonia 28
MX - Messico 25
BE - Belgio 21
ES - Italia 20
IQ - Iraq 19
SA - Arabia Saudita 17
EC - Ecuador 14
CZ - Repubblica Ceca 13
MY - Malesia 13
IR - Iran 12
BG - Bulgaria 11
AE - Emirati Arabi Uniti 10
CO - Colombia 9
MA - Marocco 9
PE - Perù 8
PK - Pakistan 7
RO - Romania 7
DO - Repubblica Dominicana 6
KE - Kenya 6
PH - Filippine 6
PT - Portogallo 6
CL - Cile 5
EU - Europa 5
LT - Lituania 5
UZ - Uzbekistan 5
AU - Australia 4
AZ - Azerbaigian 4
CH - Svizzera 4
GR - Grecia 4
PY - Paraguay 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
DZ - Algeria 3
EG - Egitto 3
JM - Giamaica 3
LB - Libano 3
MK - Macedonia 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
SN - Senegal 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
VE - Venezuela 3
HR - Croazia 2
IL - Israele 2
JO - Giordania 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MD - Moldavia 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BN - Brunei Darussalam 1
BO - Bolivia 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
KG - Kirghizistan 1
KW - Kuwait 1
ME - Montenegro 1
MN - Mongolia 1
MU - Mauritius 1
NI - Nicaragua 1
PS - Palestinian Territory 1
RE - Reunion 1
Totale 15.453
Città #
Ann Arbor 1.568
Ashburn 621
Singapore 607
Hong Kong 453
Ho Chi Minh City 435
Fairfield 433
Hanoi 390
Houston 384
Woodbridge 359
Wilmington 331
Chandler 321
Dublin 284
Jacksonville 247
New York 204
Frankfurt am Main 198
Dearborn 194
Santa Clara 171
Seattle 168
Milan 166
Beijing 152
Dallas 136
Cambridge 135
Hefei 135
Munich 121
Los Angeles 119
Princeton 112
Nanjing 83
Seoul 69
Helsinki 68
Vienna 66
Shanghai 60
Altamura 59
Lawrence 49
Chicago 48
São Paulo 48
Jakarta 46
Da Nang 43
Buffalo 41
Moscow 40
Lachine 39
Haiphong 36
Council Bluffs 35
San Diego 34
The Dalles 34
Ninh Bình 31
Quận Bình Thạnh 30
Biên Hòa 29
Boardman 29
Toronto 29
Shenyang 27
Guangzhou 26
Ha Long 26
Tokyo 26
Rome 25
Nürnberg 24
Changsha 23
Hebei 23
Hải Dương 22
London 22
Thái Nguyên 22
Brussels 21
Lissone 21
Tianjin 21
Nanchang 20
Falls Church 19
Turku 19
Andover 18
Can Tho 18
Denver 18
Dong Ket 17
Jinan 17
Fremont 16
Jiaxing 16
Orem 16
Salt Lake City 16
Genoa 15
Montréal 15
Ottawa 15
Warsaw 15
Phoenix 14
Turin 14
Bologna 13
Brooklyn 13
Bắc Ninh 13
Montreal 13
Quận Một 13
Atlanta 12
Dhaka 12
Johannesburg 12
Quận Phú Nhuận 12
Rio de Janeiro 12
Vinh 12
Kunming 11
Mexico City 11
Ningbo 11
Phủ Lý 11
Quận Sáu 11
Brno 10
Edmonton 10
Naples 10
Totale 10.339
Nome #
Radio-chemotherapy and metformin selectively modulate the heterogeneous landscape of glioma with ribosome biogenesis, long non coding RNA and immune-escape markers as major player 735
Automated radiosynthesis and preclinical evaluation of two new PSMA-617 derivatives radiolabelled via [18F]AlF2+ method 489
Study of the tissue distribution of TLQP-21 in mice using [18F]JMV5763, a radiolabeled Analog prepared via [18F]aluminum fluoride chelation chemistry 473
Treatment response assessment in [18F]FDG-PET/CT oncology scans: Impact of count statistics variation and reconstruction protocol 471
Divergent in vitro/in vivo responses to drug treatments of highly aggressive NIH-Ras cancer cells: A PET imaging and metabolomics-mass-spectrometry study 463
Cholinergic ligand [C-11]MP4A: Improved 4-acetoxypiperidine precursor synthesis via LC-APCI/MS characterisation and improved radioligand HPLC purification 407
11C-Labelling of N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]arylcarboxamide Derivatives and Evaluation as Potential Radioligands for PET imaging of Dopamine D3 Receptors 403
In vivo imaging of adenosine A2A receptors in rat and primate brain using [11C]SCH442416 389
Added diagnostic value of respiratory-gated 4D 18F–FDG PET/CT in the detection of liver lesions: a multicenter study 375
A novel versatile precursor suitable for 18F-radiolabeling via “click chemistry” 371
11C-radiosynthesis and preliminary human evaluation of the disposition of the ACE inhibitor [11C]Zofenoprilat 343
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer 302
Improved synthesis and radiolabeling of [C-11]MP4A, a suitable ligand for the investigation of the cholinergic system using PET 298
Imaging Metformin Efficacy as Add-On Therapy in Cells and Mouse Models of Human EGFR Glioblastoma 289
Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models 280
Highlight selection of radiochemistry and radiopharmacy developments by editorial board 277
Automated production of copper radioisotopes and preparation of high specific activity [(64)Cu]Cu-ATSM for PET studies 258
Quinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activation 254
Synthesis and in vivo evaluation of 3-[C-11]methyl-(3-methoxy-naphthalen)-2-yl-(1-benzyl-piperidin)-4-yl-acetate (SB-235753), as a putative dopamine D-4 receptors antagonist for PET 251
Sperimentazione clinica con radiofarmaci 246
PET imaging and single-cell RNA sequencing glioma microenvironment assessment after RT combined therapy 243
VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cells 242
[11C]RN5: A new agent for the in vivo imaging of myocardial α1-adrenoceptors 240
EANM Guideline on the validation of analytical methods for radiopharmaceuticals 236
PET radiopharmacy and automation 228
Synthesis and carbon-11 labeling of (R)- and (S)-Thionisoxetine, norepinephrine reuptake inhibitors, potential radioligands for Positron Emission Tomography 227
Quality Control in the Production of Radiopharmaceuticals 226
Radiosynthesis of [123I]βCIT, a selective ligand for the study of the dopaminergic and serotoninergic systems in human brain 224
Position paper to facilitate patient access to radiopharmaceuticals: considerations for a suitable pharmaceutical regulatory framework 221
Synthesis and in vivo evaluation of [11C]ICI 118551 as a putative subtype selective β2-adrenergic radioligand 220
Development of a bicistronic vector for multimodality imaging of estrogen receptor activity in a breast cancer model: preliminary application 218
Asymmetric synthesis and preliminary evaluation of (R)- and (S)-[11C]bisoprolol, a putative beta1-selective adrenoceptor radioligand 213
Preparation of [11C]radioligands with high specific radioactivity on a commercial PET tracer synthesizer 211
Sensitive GC-MS method for the determination of specific-activity of 16a[18F]Fluoro-estra-1,3,5(10)-triene-3,17b-diol 209
Produzione e verifiche di qualità dei radiofarmaci estemporanei per PET e terapia 208
Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approach 206
Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals 205
Systemic and cerebral kinetics of 16α[18F]fluoro-17β-estradiol: A ligand for the in vivo assessment of estrogen receptor binding parameters 205
Rsdiofarmaci marcati con fluoro-18 205
European regulations for the introduction of novel radiopharmaceuticals in the clinical setting 199
Synthesis and in vivo evaluation of [C-11]CGP62349, a new GABA(B) receptor antagonist 198
Labeling and evaluation of N-[11C]methylated quinoline-2-carboxamides as potential radioligands for visualization of peripheral benzodiazepine receptors 198
Synthesis and Biodistribution of (R,S)-[O-Methyl-11C]-1-[3-(5-Methoxy-1,2,3,4-Tetrahydro-1-Naphtalenyl)Propyl]-4-Phenylpiperazine (PNU-157760), A Putative Radioligand for 5-HT1A Receptors 194
Measurements and evaluation of the risks due to external radiation exposures and to intake of activated elements for operational staff engaged in the maintenance of medical cyclotrons 193
Clinical Application of a High Sensitivity BGO PET/CT Scanner: Effects of Acquisition Protocols and Reconstruction Parameters on Lesions Quantification 191
Automation of [C-11]acyl chloride syntheses using commercially available C-11-modules 190
EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD) 190
Intake risk and dose evaluation methods for workers in radiochemistry labs of a medical cyclotron facility 189
Measurement and control of the air contamination generated in a medical cyclotron facility for PET radiopharmaceuticals 188
High yield synthesis of [11C]-acetone through selective quenching of methyl lithium 178
Decommissioning procedures for an 11 MeV self-shielded medical cyclotron after 16 years of working time 171
PET in psychopharmacology 162
Synthesis of [O-methyl-11c]fluvoxamine-a potential serotonin uptake site radioligand 160
Design, radiosynthesis, and biodistribution of a new potent and selective ligand for in vivo imaging of the adenosine A2A receptor system using positron emission tomography [2] 156
Guidance on validation and qualification of processes and operations involving radiopharmaceuticals 154
Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals 138
From radiotracer to radiopharmaceutical: a philosophical approach 134
A PET follow-up study of recovery after stroke in acute aphasics 131
EANM guideline on quality risk management for radiopharmaceuticals 127
Classificazione ambientale 121
Practical considerations for navigating the regulatory landscape of non-clinical studies for clinical translation of radiopharmaceuticals 120
Position paper on requirements for toxicological studies in the specific case of radiopharmaceuticals 119
Highlight selection of radiochemistry and radiopharmacy developments by editorial board 119
Mild synthesis of [N-methyl-11C]-isovaleroyl-(L)-carnitine. The usefulness of a tritium approach. 112
Guidance on current good radiopharmacy practice for the small-scale preparation of radiopharmaceuticals using automated modules: A European perspective 109
Radiopharmaceutical need between the clinic and regulatory agencies: how philosophy could explain 'the road taken' 104
Automated fluorine-18 radiolabeling via an alkyne–azide cycloaddition reaction on a dual peptide-functionalized liposome surface for in vivo PET imaging 47
Totale 15.853
Categoria #
all - tutte 49.088
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.088


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021885 0 0 0 0 0 120 140 112 127 136 106 144
2021/20221.021 89 111 168 136 35 59 62 69 49 59 77 107
2022/20231.344 164 387 84 134 100 197 26 78 71 19 57 27
2023/20241.109 44 40 56 39 147 310 211 40 85 12 8 117
2024/20252.572 137 251 120 98 217 179 202 158 239 341 207 423
2025/20264.340 1.558 742 508 736 704 92 0 0 0 0 0 0
Totale 15.853